NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/03/2025
Back to search
Official data from USPTO
BIOPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
06/03/2025
Trademark type
Combined
Nice classes
35
Filing date
11/06/2023
Registration date
06/03/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2025
Last transaction
06/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2023-06-00
First use in commerce
2023-06-00
Drawing code
3
Owner type
16
Owner location
New Hope, PA
Examiner
FLEBBE, KEVIN ROBERT
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "BIOPHARM" in the color black with a multi-color design of dots appearing above and below the word "BIOPHARM" with the dots appearing in the colors purple and orange.
Holders and representatives
Holders
BioPharm Communications, LLC
Representatives
Jordan A. LaVine FLASTER GREENBERG PC
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business marketing and promotional services in the field of healthcare; business consulting and marketing services in the field of healthcare; providing demand creation and lead generation activities and services in the field of healthcare; marketing consultationcustomer targeting consultancy services in the field of healthcare; advertising servicespromoting and marketing the goods and services of others in the healthcare field through all public communication means; advertising and marketing services provided by means of indirect methods of marketing communicationssocial mediasearch engine marketinginquiry marketinginternet marketingmobile marketingblogging and other forms of passivesharable or viral communications channels in the field of healthcare; advertising and marketing servicespromoting the goods and services of others in the field of healthcare; analysis of market research data and statistics in the field of healthcare; business management consulting with relation to strategymarketingsalesoperationproduct design particularly specializing in the use of analytic and statistic models for the understanding and predicting of consumersbusinessesmarket trends and actions in the field of healthcare; marketing services for others in the nature of using analytics to understanding and predict consumersbusinessesmarket trends and actions; direct marketing services in the field of healthcare; collection of market research information in the field of healthcare; computerized market research services in the field of healthcare; direct marketing consulting services in the field of healthcare; market analysis and research services in the field of health care; market intelligence services in the field of healthcare; marketing analysis services in the field of healthcare; marketing and consulting services in the field of promoting and tracking the goodsservicesbrands of others through all public communication meansparticularly specializing in the use of mobilesocialprint media to drive consumer interestengagement and action in the field of healthcare; providing demand creation and lead generation activities and services in the field of healthcare; providing advertisingmarketing and promotional services for the healthcarepharmaceutical and medical industries
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/15/2025
PUBO
PUBLISHED FOR OPPOSITION
04/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/18/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/18/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/18/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/18/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/26/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/30/2024
GNRT
NON-FINAL ACTION E-MAILED
06/30/2024
CNRT
NON-FINAL ACTION WRITTEN
06/30/2024
DOCK
ASSIGNED TO EXAMINER
06/14/2024
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/30/2023
NWAP
NEW APPLICATION ENTERED
11/09/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.